First Time Loading...
M

Mayinglong Pharmaceutical Group Co Ltd
SSE:600993

Watchlist Manager
Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
Watchlist
Price: 27.42 CNY 1.56% Market Closed
Updated: Apr 27, 2024

Mayinglong Pharmaceutical Group Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mayinglong Pharmaceutical Group Co Ltd
Revenue Peer Comparison

Comparables:
C
1093
H
3692
600436
600276
000538

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
M
Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
Revenue
¥3.2B
CAGR 3-Years
8%
CAGR 5-Years
8%
CAGR 10-Years
7%
C
CSPC Pharmaceutical Group Ltd
HKEX:1093
Revenue
¥31.5B
CAGR 3-Years
8%
CAGR 5-Years
12%
CAGR 10-Years
15%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Revenue
¥10.1B
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Revenue
¥9.7B
CAGR 3-Years
14%
CAGR 5-Years
16%
CAGR 10-Years
22%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Revenue
¥22.3B
CAGR 3-Years
-5%
CAGR 5-Years
7%
CAGR 10-Years
14%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Revenue
¥39.1B
CAGR 3-Years
6%
CAGR 5-Years
8%
CAGR 10-Years
9%

See Also

What is Mayinglong Pharmaceutical Group Co Ltd's Revenue?
Revenue
3.2B CNY

Based on the financial report for Sep 30, 2023, Mayinglong Pharmaceutical Group Co Ltd's Revenue amounts to 3.2B CNY.

What is Mayinglong Pharmaceutical Group Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
7%

Over the last year, the Revenue growth was -12%. The average annual Revenue growth rates for Mayinglong Pharmaceutical Group Co Ltd have been 8% over the past three years , 8% over the past five years , and 7% over the past ten years .